Soligenix Inc. announced today that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised its option to advance preclinical development of OrbeShield, a medical countermeasure for the treatment of gastrointestinal acute radiation syndrome (GI ARS).
The U.S. Environmental Protection Agency is proposing two new hazardous waste rules to strengthen environmental protection while reducing regulatory burden on businesses. The proposed rules will protect waterways and provide greater flexibility to industry while requiring new safeguards to protect the public from mismanagement of hazardous waste.
An interdisciplinary research team led by The University of Texas Medical Branch at Galveston reports a new breakthrough in countering the deadly effects of radiation exposure. A single injection of a regenerative peptide was shown to significantly increase survival in mice when given 24 hours after nuclear radiation exposure.
Pfenex Inc. announced it has signed a five-year, cost-plus-fixed-fee contract valued at up to $143.5 million with the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), for the advanced development of Px563L, a mutant recombinant protective antigen anthrax vaccine.
With the opening of the Systems Engineering Building at the Department of Energy's Pacific Northwest National Laboratory, a new suite of capabilities becomes available to researchers and industry to tackle the nation's top challenges in grid modernization, buildings efficiency, and renewable energy integration.
Thermo Fisher Scientific announces the launch of its RadHalo rapid deployment probe (RDP) and fixed monitor (FM), which offer hands-free technology for security personnel, military teams, and first responders. These high-precision spectroscopy instruments are the first products in a new line of radiation identification area monitors.
Governor Cuomo announced the creation of "NY Responds" a comprehensive new approach for coordinating and strengthening the State's emergency preparedness. As part of NY Responds, for the first time ever, every county in New York State will have access to universal emergency management software.
A new anthrax vaccine that could be easier and faster to produce than the existing licensed product will undergo initial clinical studies through an agreement between the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response and Pfenex, Inc. of San Diego.
The next generation in biocontainment systems was unveiled in a recent ceremony at Dobbins Air Reserve Base, Georgia. The Containerized Biocontainment Systems (CBCS) is a self-contained, roll on, roll off solution that can be used on a variety of commercial and military aircraft and easily decontaminated and stored indefinitely without significant maintenance requirements.
Emergent BioSolutions Inc announced that the Centers for Disease Control and Prevention has exercised options under existing contract for the supply of Vaccinia Immune Globulin (VIGIV) into the U.S. Strategic National Stockpile. VIGIV is a therapeutic licensed by the U.S. Food and Drug Administration for the treatment of complications due to smallpox vaccination.
